AIMT

Aimmune Therapeutics, Inc.
AIMT

Delisted

AIMT was delisted on the 12th of October, 2020.

161 hedge funds and large institutions have $712M invested in Aimmune Therapeutics, Inc. in 2020 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 43 increasing their positions, 45 reducing their positions, and 38 closing their positions.

Holders
161
Holders Change
+6
Holders Change %
+3.87%
% of All Funds
3.56%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
46
Increased
43
Reduced
45
Closed
38
Calls
$6.47M
Puts
$5.23M
Net Calls
+$1.25M
Net Calls Change
-$6.73M
Name Market Value Shares Shares
Change
Shares
Change %
GC
176
Guggenheim Capital
Illinois
-10,008 Closed
AIM
177
Aigen Investment Management
New York
-9,535 Closed
Principal Financial Group
178
Principal Financial Group
Iowa
-9,148 Closed
AG
179
Aperio Group
California
-9,124 Closed
ACM
180
AlphaCrest Capital Management
New York
-9,000 Closed
CCIA
181
Campbell & Co Investment Adviser
Maryland
-8,459 Closed
AB
182
Amalgamated Bank
New York
-8,438 Closed
XK
183
Xact Kapitalforvaltning
Sweden
-8,100 Closed
LPL Financial
184
LPL Financial
California
-7,944 Closed
PPW
185
Parcion Private Wealth
Washington
-6,984 Closed
PFS
186
Prospera Financial Services
Texas
-6,803 Closed
BFM
187
Boothbay Fund Management
New York
-6,640 Closed
CIA
188
Capital Investment Advisors
Georgia
-6,000 Closed
CM
189
Caption Management
Oklahoma
-5,000 Closed
MA
190
MYDA Advisors
New York
-4,000 Closed
OIA
191
Optimum Investment Advisors
Illinois
-2,500 Closed
IAS
192
IMA Advisory Services
Colorado
-432 Closed
EW
193
Evoke Wealth
California
-297 Closed
HMS
194
Hanseatic Management Services
New Mexico
-87 Closed
GWS
195
Glassman Wealth Services
Virginia
-19 Closed
OPS
196
Orion Portfolio Solutions
Nebraska
-12 Closed
HT
197
HAP Trading
New York
HWM
198
HighMark Wealth Management
Minnesota
$0 31
S
199
SignatureFD
Georgia
$0 1
VCM
200
Versant Capital Management
Arizona
$0 46 +46 New